13F HOLDINGS REPORT
Soleus Capital Management, L.P.
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001802630-24-000008
Total Value
$1.13B
Positions
92
Other Managers
0
Confidential Omitted
No
Holdings (92)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TG THERAPEUTICS INC | TGTX | 3,645,562 | $64.9M | 5.72% |
| 2 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 7,548,000 | $60.5M | 5.34% |
| 3 | UNITED THERAPEUTICS CORP DEL | UTHR | 141,499 | $45.1M | 3.97% |
| 4 | NURIX THERAPEUTICS INC | NRIX | 2,055,916 | $42.9M | 3.78% |
| 5 | EDAP TMS S A | EDAP | 7,293,728 | $39.7M | 3.50% |
| 6 | TERNS PHARMACEUTICALS INC | TERN | 4,947,738 | $33.7M | 2.97% |
| 7 | REVOLUTION MEDICINES INC | RVMDW | 856,178 | $33.2M | 2.93% |
| 8 | SURMODICS INC | 868873100 | 781,777 | $32.9M | 2.90% |
| 9 | ORGANOGENESIS HLDGS INC | ORGO | 11,518,954 | $32.3M | 2.84% |
| 10 | JASPER THERAPEUTICS INC | JSPRW | 1,276,190 | $29.0M | 2.55% |
| 11 | IDEAYA BIOSCIENCES INC | IDYA | 694,069 | $24.4M | 2.15% |
| 12 | AXOGEN INC | AXGN | 3,305,815 | $23.9M | 2.11% |
| 13 | KRYSTAL BIOTECH INC | KRYS | 126,000 | $23.1M | 2.04% |
| 14 | MERUS N V | N5749R100 | 376,321 | $22.3M | 1.96% |
| 15 | PENUMBRA INC | PEN | 123,450 | $22.2M | 1.96% |
| 16 | ESSA PHARMA INC | 29668H708 | 4,210,537 | $22.1M | 1.95% |
| 17 | PRAXIS PRECISION MEDICINES I | PRAX | 533,015 | $22.0M | 1.94% |
| 18 | CELCUITY INC | CELC | 1,211,187 | $19.8M | 1.75% |
| 19 | INARI MED INC | 45332Y109 | 408,373 | $19.7M | 1.73% |
| 20 | BEIGENE LTD | BEIGF | 137,700 | $19.6M | 1.73% |
| 21 | C4 THERAPEUTICS INC | CCCC | 4,051,996 | $18.7M | 1.65% |
| 22 | CASTLE BIOSCIENCES INC | CSTL | 853,628 | $18.6M | 1.64% |
| 23 | NEUROPACE INC | NPCE | 2,433,168 | $18.4M | 1.62% |
| 24 | ENLIVEN THERAPEUTICS INC | ELVN | 769,263 | $18.0M | 1.59% |
| 25 | ALNYLAM PHARMACEUTICALS INC | ALNY | 71,700 | $17.4M | 1.54% |
| 26 | SYNDAX PHARMACEUTICALS INC | SNDX | 826,500 | $17.0M | 1.50% |
| 27 | HUMANA INC | HUM | 44,356 | $16.6M | 1.46% |
| 28 | GSK PLC | GLAXF | 415,000 | $16.0M | 1.41% |
| 29 | TREACE MED CONCEPTS INC | 89455T109 | 2,365,648 | $15.7M | 1.39% |
| 30 | VAXCYTE INC | PCVX | 185,250 | $14.0M | 1.23% |
| 31 | 10X GENOMICS INC | TXG | 719,000 | $14.0M | 1.23% |
| 32 | CG ONCOLOGY INC | CGON | 424,585 | $13.4M | 1.18% |
| 33 | NUVALENT INC | NUVL | 171,788 | $13.0M | 1.15% |
| 34 | EVOLUS INC | EOLS | 1,152,000 | $12.5M | 1.10% |
| 35 | ENANTA PHARMACEUTICALS INC | ENTA | 799,546 | $10.4M | 0.91% |
| 36 | ALECTOR INC | ALEC | 2,239,006 | $10.2M | 0.90% |
| 37 | KEROS THERAPEUTICS INC | KROS | 221,600 | $10.1M | 0.89% |
| 38 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 586,499 | $9.5M | 0.84% |
| 39 | ARCELLX INC | ACLX | 170,741 | $9.4M | 0.83% |
| 40 | BIODESIX INC | BDSX | 6,111,964 | $9.4M | 0.82% |
| 41 | TANGO THERAPEUTICS INC | TNGX | 1,049,895 | $9.0M | 0.79% |
| 42 | ORTHOPEDIATRICS CORP | KIDS | 309,500 | $8.9M | 0.78% |
| 43 | RIGEL PHARMACEUTICALS INC | RIGL | 1,043,697 | $8.6M | 0.76% |
| 44 | BAUSCH HEALTH COS INC | 071734107 | 1,206,000 | $8.4M | 0.74% |
| 45 | IMMUNIC INC | IMUX | 7,293,007 | $8.1M | 0.71% |
| 46 | Y-MABS THERAPEUTICS INC | 984241109 | 647,982 | $7.8M | 0.69% |
| 47 | ENGENE HOLDINGS INC | ENGNW | 800,000 | $7.5M | 0.67% |
| 48 | PHARVARIS N V | PHVS | 399,430 | $7.5M | 0.66% |
| 49 | AVADEL PHARMACEUTICALS PLC | G29687103 | 509,000 | $7.2M | 0.63% |
| 50 | DYNE THERAPEUTICS INC | DYN | 201,000 | $7.1M | 0.63% |
| 51 | CVRX INC | CVRX | 587,098 | $7.0M | 0.62% |
| 52 | INSMED INC | INSM | 102,472 | $6.9M | 0.61% |
| 53 | HIMS & HERS HEALTH INC | HIMS | 333,000 | $6.7M | 0.59% |
| 54 | THERATECHNOLOGIES INC | 88338H704 | 4,801,376 | $6.7M | 0.59% |
| 55 | IMMUNOVANT INC | IMVT | 251,900 | $6.7M | 0.59% |
| 56 | ADAPTIVE BIOTECHNOLOGIES COR | ADTI | 1,720,000 | $6.2M | 0.55% |
| 57 | APPLIED THERAPEUTICS INC | 03828A101 | 1,269,714 | $5.9M | 0.52% |
| 58 | GLOBUS MED INC | GMED | 86,000 | $5.9M | 0.52% |
| 59 | JAZZ PHARMACEUTICALS PLC | JAZZ | 53,935 | $5.8M | 0.51% |
| 60 | BIOATLA INC | BCAB | 3,901,314 | $5.3M | 0.47% |
| 61 | ERASCA INC | ERAS | 2,162,162 | $5.1M | 0.45% |
| 62 | VERASTEM INC | VSTM | 1,661,297 | $5.0M | 0.44% |
| 63 | MEREO BIOPHARMA GROUP PLC | MREO | 1,246,953 | $4.5M | 0.40% |
| 64 | IRADIMED CORP | IRMD | 102,067 | $4.5M | 0.40% |
| 65 | VIRIDIAN THERAPEUTICS INC | VRDN | 340,000 | $4.4M | 0.39% |
| 66 | EXACT SCIENCES CORP | 30063P105 | 91,611 | $3.9M | 0.34% |
| 67 | INSULET CORP | PODD | 18,800 | $3.8M | 0.33% |
| 68 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 200,000 | $3.7M | 0.33% |
| 69 | INSPIREMD INC | NSPR | 1,378,128 | $3.4M | 0.30% |
| 70 | CALCIMEDICA INC | CALC | 783,904 | $3.1M | 0.27% |
| 71 | THE BEAUTY HEALTH COMPANY | 88331L108 | 1,604,718 | $3.1M | 0.27% |
| 72 | SANOFI | SNYNF | 62,500 | $3.0M | 0.27% |
| 73 | FATE THERAPEUTICS INC | FATE | 870,000 | $2.9M | 0.25% |
| 74 | X4 PHARMACEUTICALS INC | XFOR | 4,051,000 | $2.3M | 0.21% |
| 75 | OLEMA PHARMACEUTICALS INC | OLMA | 216,500 | $2.3M | 0.21% |
| 76 | JANUX THERAPEUTICS INC | JANX | 55,500 | $2.3M | 0.21% |
| 77 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 108,598 | $2.3M | 0.20% |
| 78 | GENEDX HOLDINGS CORP | WGSWW | 87,000 | $2.3M | 0.20% |
| 79 | CERVOMED INC | CRVO | 126,614 | $2.2M | 0.19% |
| 80 | AVITA MEDICAL INC | AVHHL | 267,000 | $2.1M | 0.19% |
| 81 | NOVOCURE LTD | NVCR | 108,900 | $1.9M | 0.16% |
| 82 | INHIBRX BIOSCIENCES INC | INBX | 88,470 | $1.3M | 0.11% |
| 83 | ORIC PHARMACEUTICALS INC | ORIC | 163,000 | $1.2M | 0.10% |
| 84 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 147,246 | $1.0M | 0.09% |
| 85 | ESTABLISHMENT LABS HLDGS INC | ESTA | 15,000 | $681,600 | 0.06% |
| 86 | ORTHOFIX MED INC | OFIX | 51,000 | $676,260 | 0.06% |
| 87 | MIMEDX GROUP INC | MDXG | 82,884 | $574,386 | 0.05% |
| 88 | AADI BIOSCIENCE INC | WHWK | 333,227 | $486,511 | 0.04% |
| 89 | BICYCLE THERAPEUTICS PLC | BCYC | 23,500 | $475,640 | 0.04% |
| 90 | NATERA INC | NTRA | 3,600 | $389,844 | 0.03% |
| 91 | IO BIOTECH INC | IOBT | 192,670 | $225,424 | 0.02% |
| 92 | XERIS BIOPHARMA HOLDINGS INC | XERS | 62,083 | $139,687 | 0.01% |